TİP 2 DİYABETES MELLİTUSLU HASTALARIN HİPOGLİSEMİK GÜVENLERİ VE HİPOGLİSEMİ KORKULARI ARASINDAKİ İLİŞKİ

Amaç: Bu çalışmanın amacı, tip 2 diyabetes mellituslu hastaların hipoglisemik güvenleri ve hipoglisemi korkuları arasındaki ilişkiyi belirlemektir. Yöntem: Tanımlayıcı ve kesitsel olarak tasarlanan bu araştırma, Aralık 2021 ve Şubat 2022 tarihleri arasında diyabet polikliniğine muayene olmak için gelen 306 tip 2 diyabetli hasta ile tamamlandı. Veriler, “Hasta Tanıtım Formu”, “Hipoglisemik Güven Ölçeği (HGÖ)” ve “Hipoglisemi Korku Ölçeği (HKÖ)” kullanılarak elde edildi. Verilerin değerlendirilmesinde, tanımlayıcı istatistikler, Independent-Samples t testi, One-Way ANOVA testi, Pearson Korelasyon ve Linear Regresyon analizi kullanıldı. Bulgular: Araştırmaya katılan Tip 2 diyabetli hastaların %60.8’i kadın olup yaş ortalaması 55.14±8.10 ve hastalık yılı ortalaması 10.35±4.77 idi. Tip 2 diyabetli hastaların HGÖ puan ortalamasının 1.65±0.47 ve HKÖ puan ortalamasının 3.02±0.56 olduğu belirlendi. HGÖ toplam puanı ile HKÖ toplam, HKÖ Davranış ve Kaygı alt boyutu arasında orta derecede negatif yönlü bir ilişki olduğu saptandı (p

Anahtar Kelimeler:

Tip 2 Diyabetes Mellitus, Hipoglisemi, Korku

THE RELATIONSHIP BETWEEN HYPOGLYCEMIC CONFIDENCE AND HYPOGLYCEMIA FEAR IN TYPE 2 DIABETES MELLITUS PATIENTS

Objective: This study aims to identify the relationship between hypoglycemic confidence and hypoglycemia fear in type 2 diabetes mellitus patients. Method: Designed as a descriptive and cross-sectional study, this research was conducted with 306 type 2 diabetes patients who visited the diabetes polyclinic to have an examination in period December 2021 and February 2022. The research data were collected by using the “Patient Identification Form”, the “Hypoglycemic Confidence Scale”, and the “Hypoglycemia Fear Survey”. Descriptive statistics, the Independent Samples t-test, the One-Way ANOWA test, the Pearson’s correlation test, and the linear regression analysis were used in the evaluation of research data. Results: In the research, 60.8% of the participant type 2 diabetes patients were female, their mean age was 55.14±8.10 years, and their mean duration of having the disease was 10.35±4.77 years. Means of type 2 diabetes patients’ Hypoglycemic Confidence Scale (HCS)’ score 1.65±0.47 and ‘Hypoglycemia Fear Survey (HFS)’ scores were 3.02±0.56 points. Type 2 diabetes patients’ HCS scores had moderately negative relationships with scores obtained by them from the HFS and its Behavior Sub-scale and Worry Sub-scale (p

Keywords:

Type 2 Diabetes Mellitus, Hypoglycemia, Fear,

PDF

___

Rossi MC, Nicolucci A, Ozzello A, et al. Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. Nutr Metab Cardiovasc Dis. 2019;29(7):736-743.
Khunti K, Alsifri S, Aronson R, Berković MC, Enters-Weijnen C, Forsén T. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. Diabetes Res Clin Pract. 2017;130:121-129.
Freeman J. Management of hypoglycemia in older adults with type 2 diabetes. Postgrad Med. 2019;131(4):241-250.
Johnson-Rabbett B, Seaquist ER. Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review. J Diabetes. 2019;11(9):711-718.
Ratzki-Leewing A, Harris SB, Mequanint S, et al. Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada. BMJ Open Diabetes Res Care. 2018;6(1):1-9.
Emral R, Tetiker T, Sahin I, et al. An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study. BMC Endocr Disord. 2018;18(1):1-11.
Gonder-Frederick LA, Vajda KA, Schmidt KM, et al. Examining the behaviour subscale of the Hypoglycaemia Fear Survey: an international study. Diabet Med. 2013;30(5):603-609.
Polonsky WH, Fisher L, Hessler D, Edelman SV. Investigating hypoglycemic confidence in Type 1 and Type 2 diabetes. Diabetes Technol Ther. 2017;19(2):131-136.
Büyükkaya BD, Dervişoğlu M. Hipoglisemik güven ölçeği'nin geçerlik ve güvenirliği. Turkiye Klinikleri Hemşirelik Bilimleri. 2021;13(1):120-129.
Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987;10(5):617-621.
Erol Ö, Enç N. Hypoglycemia fear and self-efficacy of Turkish patients receiving insulin therapy. Asian Nurs Res. 2011;5(4):222-228.
Ahmad I, Zelnick LR, Batacchi Z, et al. Hypoglycemia in people with type 2 diabetes and CKD. Clin J Am Soc Nephrol. 2019;14(6):844-853.
Wang JS, Chen H, Tang F, Sheu WHH. Associations of fear of hypoglycemia with second-line use of insulin secretagogues or insulin and subsequent glycemic control in patients with type 2 diabetes: An analysis using data from the DISCOVER study. Int J Clin Pract. 2020;74(6):e13485.
Huang J, Ding S, Xiong S, Liu Z. The mediating effects of diabetes distress, anxiety, and cognitive fusion on the association between neuroticism and fear of hypoglycemia in patients with type 2 diabetes. Front Psychol. 2021;12:1-11.
Sheikhi M, Moradi M, Shahsavary S, Alimoradi Z, Salimi HR. The effect of eye movement desensitization and reprocessing on the fear of hypoglycemia in type 2 diabetic patients: a randomized clinical trial. BMC Psychol. 2020;8(1):1-8.
Grammes J, Schäfer M, Benecke A, et al. Fear of hypoglycemia in patients with type 2 diabetes: The role of interoceptive accuracy and prior episodes of hypoglycemia. J Psychosom Res. 2018;105:58-63.
Al Hayek AA, Robert AA, Al Dawish MA. Evaluation of FreeStyle Libre flash glucose monitoring system on glycemic control, health-related quality of life, and fear of hypoglycemia in patients with type 1 diabetes. Clin Med Insights: Endocrinol Diabetes. 2017;10:1-8.
Yuksel M, Bektas H. Compliance with treatment and fear of hypoglycaemia in patients with type 2 diabetes. J Clin Nurs. 2021;30(11-12):1773-1786.
YekeFallah L, Namdar P, Jalalpour A, Talebi F, Mafi MH. The relationship between fear of hypoglycemia and sleep quality among type 2 diabetic patients. Clinical Diabetology. 2021;10(1):149-154.
Hapunda G, Abubakar A, Pouwer F, Van De Vijver F. Correlates of fear of hypoglycemia among patients with type 1 and 2 diabetes mellitus in outpatient hospitals in Zambia. Int J Diabetes Dev Ctries. 2020;40(4):619-626.
Li S, Fang L, Lee A, et al. The association between diabetes-related distress and fear of hypoglycaemia in patients with type 2 diabetes mellitus: A cross-sectional descriptive study. Nurs Open. 2021;8(4):1668-1677.
Kalra S, Das AK, Priya G, et al. An expert opinion on “glycemic happiness”: delineating the concept and determinant factors for persons with type 2 diabetes mellitus. Clin Pract. 2021;11(3):543-560.
Brown JB, Reichert SM, Valliere Y, et al. Living with hypoglycemia: an exploration of patients’ emotions: qualitative findings from the InHypo-DM study, Canada. Diabetes Spectr. 2019;32(3):270-276.
Ólafsdóttir AF, Polonsky W, Bolinder J, et al. A randomized clinical trial of the effect of continuous glucose monitoring on nocturnal hypoglycemia, daytime hypoglycemia, glycemic variability, and hypoglycemia confidence in persons with type 1 diabetes treated with multiple daily insulin injections (GOLD-3). Diabetes Technology & Therapeutics. 2018;20(4):274-284.
Kalra S, Das AK, Priya G, et al. An expert opinion on “glycemic happiness”: delineating the concept and determinant factors for persons with type 2 diabetes mellitus. Clin Pract. 2021;11(3):543-560.
Sakane N, Kotani K, Tsuzaki K, et al. Fear of hypoglycemia and its determinants in insülin-treated patients with type 2 diabetes mellitus. J Diabetes Investig. 2015;6(5):567-570.
Tourkmani AM, Alharbi TJ, Rsheed AMB, et al. Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;12(5):791-794.